> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Draft Guide on Heart Failure Drug Endpoints
- URL: https://www.fdaweb.com/draft-guide-on-heart-failure-drug-endpoints/
- Published: 2019-06-28T12:00:00.000Z
- Updated: 2026-09-15T01:35:44.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5144449

*Federal Register* notice: FDA has made available a draft guidance entitled “Treatment for Heart Failure: Endpoints for Drug Development.” The document clarifies that an effect on symptoms or physical function, without a favorable effect on survival or hospitalization, can be a basis for approving drugs to treat heart failure. It also provides recommendations to sponsors on the need to assess mortality effects of drugs under development to treat heart failure. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2019-06-28/pdf/2019-13800.pdf?ref=fdaweb.com).